Ignite Creation Date:
2024-05-06 @ 12:42 PM
Last Modification Date:
2024-10-26 @ 1:03 PM
Study NCT ID:
NCT03829579
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2020-02-10
First Post:
2019-02-01
Brief Title:
Pre-Approval Access to Esketamine Nasal Spray for the Treatment of Treatment-Resistant Depression TRD
Sponsor:
Janssen Research Development LLC
Organization:
Janssen Research Development LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2019-02-01
First Submit QC Date:
February 1 2019
Study First Post Date:
2019-02-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-06
Last Update Post Date:
2020-02-10
Last Update Post Date Type:
ACTUAL